SEI Medical PCL

SEI Medical PCL Net Margin

The Net Profit Margin of SEI Medical PCL (SEI.BK) as of Oct 27, 2026 is 10.34 %. In the previous year, Net Profit Margin was 11.76 % — a change of -12.10% (lower).

Net Margin

10.34 %

YoY

-12.10%

Last updated:

Net Profit Margin of SEI Medical PCL is 2025 10.34 % . Net Profit Margin of SEI Medical PCL was 2024 11.76 % . It decreases by -12.10% lower compared to the previous year.

SEI Medical PCL's net margin stands at 10.4%, up from 5.6% several years earlier.

The SEI Medical PCL Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2022
5.57 THB
Jan 1, 2023
5.56 THB
Jan 1, 2024
11.76 THB
Jan 1, 2025
10.34 THB
The SEI Medical PCL Net Margin history
YEARNet MarginYoY
10.34 %-12.10%
11.76 %+111.70%
5.56 %-0.28%
5.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SEI Medical PCL Stock analysis

What does SEI Medical PCL do? SEI Medical PCL generates revenue through the distribution and leasing of medical equipment and laboratory instruments. The company's primary products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment, and laboratory equipment, sold across its Scientific equipment and medical equipment segments. Service contracts form another key revenue stream, covering maintenance and support for medical devices. The firm serves healthcare providers and institutions requiring diagnostic and treatment solutions, leveraging its Bangkok headquarters to operate within Thailand's medical sector. The company's business model focuses on selling scientific and medical equipment, offering service contracts, and providing medical equipment lease agreements. Its segments are clearly defined as Scientific equipment and medical equipment, with service as a separate offering. Revenue is derived from direct sales to hospitals, clinics, and laboratories, as well as from long-term lease contracts. The firm's IPO on September 24, 2024, marks its entry into public markets, though it continues to rely on its established distribution network for growth. SEI Medical PCL's core operations involve the sale of specialized medical equipment including endoscopy, surgical, and neonatal care devices, alongside laboratory instruments. The service segment provides essential maintenance and technical support, enhancing customer retention. The company targets healthcare facilities seeking comprehensive solutions for diagnostic and therapeutic procedures, positioning itself as a key supplier in Thailand's medical equipment market. SEI Medical PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SEI Medical PCL stock

Net Profit Margin of SEI Medical PCL is 10.34 % in 2025.

Net Profit Margin of SEI Medical PCL changed from 11.76 % to 10.34 %, representing a -12.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin SEI Medical PCL since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's SEI Medical PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — SEI Medical PCL

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — SEI Medical PCL